Recent Quotes
My Watchlist
Indicators
Local Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Axogen, Inc. - Common Stock (NQ:AXGN)

11.37 -1.22 (-9.73%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,705,644
Open 12.87
Bid (Size) 11.37 (50)
Ask (Size) 11.71 (1)
Prev. Close 12.59
Today's Range 11.23 - 12.94
52wk Range 5.650 - 21.00
Shares Outstanding 41,397,053
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Which stocks are gapping on Thursday?
Let's delve into the US markets on Thursday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks. 
Via Chartmill
Axogen, Inc. Reports 2025 First Quarter Financial Results
From Axogen, Inc.
Via GlobeNewswire

Performance

YTD
-30.7%
-30.7%
1 Month
-28.6%
-28.6%
3 Month
-38.0%
-38.0%
6 Month
-14.4%
-14.4%
1 Year
+93.6%
+93.6%

More News

Read More
Axogen Announces Chief Financial Officer Transition
From Axogen, Inc.
Via GlobeNewswire
Earnings Scheduled For May 8, 2025
Via Benzinga
Analyst Expectations For Axogen's Future
Via Benzinga
Earnings Scheduled For February 25, 2025
Via Benzinga
Axogen, Inc. to report 2025 first quarter financial results on May 8, 2025
From Axogen, Inc.
Via GlobeNewswire
Axogen Announces Appointment of Rick Ditto as Vice President, Global Health Economics, Reimbursement & Policy, and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Axogen, Inc.
Via GlobeNewswire
This Blueprint Medicines Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Via Benzinga
Axogen, Inc. To Host Analyst & Investor Day on March 4th
From Axogen, Inc.
Via GlobeNewswire
Axogen, Inc. Reports 2024 Fourth Quarter and Full-Year Financial Results
From Axogen, Inc.
Via GlobeNewswire
Axogen, Inc. to report 2024 fourth quarter and full year financial results on February 25, 2025
From Axogen, Inc.
Via GlobeNewswire
Axogen Announces Appointment of Jesse Bishop as Vice President of Regulatory Affairs and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Axogen, Inc.
Via GlobeNewswire
Axogen Announces New VP of Operations and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Axogen, Inc.
Via GlobeNewswire
Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2024
From Axogen, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Axogen, Inc Reports Third Quarter 2024 Financial Results and Provides BLA Update
From Axogen, Inc.
Via GlobeNewswire
Axogen, Inc. to report third quarter 2024 financial results and host conference call on November 7, 2024
From Axogen, Inc.
Via GlobeNewswire
Axogen Completes Submission of Biologics License Application to U.S. Food and Drug Administration for Avance Nerve Graft®
From Axogen, Inc.
Via GlobeNewswire
Axogen Reports Inducement Grant to New Employee Under NASDAQ Listing Rule 5635(C)(4)
From Axogen, Inc.
Via GlobeNewswire
CytoSorbents Appoints Peter J. Mariani Chief Financial Officer
From CytoSorbents
Via GlobeNewswire
AXGN Stock Earnings: Axogen Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Parker-Hannifin Posts Upbeat Earnings, Joins Under Armour, Zillow Group, YETI Holdings, Eli Lilly And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Axogen, Inc. Announces New Leadership Appointments
From Axogen, Inc.
Via GlobeNewswire
Axogen, Inc. Reports Second Quarter 2024 Financial Results
From Axogen, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Axogen, Inc. - Common Stock publicly traded?
Yes, Axogen, Inc. - Common Stock is publicly traded.
What exchange does Axogen, Inc. - Common Stock trade on?
Axogen, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Axogen, Inc. - Common Stock?
The ticker symbol for Axogen, Inc. - Common Stock is AXGN on the Nasdaq Stock Market
What is the current price of Axogen, Inc. - Common Stock?
The current price of Axogen, Inc. - Common Stock is 11.37
When was Axogen, Inc. - Common Stock last traded?
The last trade of Axogen, Inc. - Common Stock was at 05/09/25 04:00 PM ET
What is the market capitalization of Axogen, Inc. - Common Stock?
The market capitalization of Axogen, Inc. - Common Stock is 470.48M
How many shares of Axogen, Inc. - Common Stock are outstanding?
Axogen, Inc. - Common Stock has 470M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.